PubRank
Search
About
OUTpatient Treatment of COVID-19 in Patients With Risk Factor for Poor Outcome (OUTCOV)
Clinical Trial ID NCT04365582
PubWeight™ 0.00
‹?›
🔗 Visit the ClinicalTrials.gov page for NCT04365582
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.
Int J Antimicrob Agents
2020
4.49
2
Recycling of chloroquine and its hydroxyl analogue to face bacterial, fungal and viral infections in the 21st century.
Int J Antimicrob Agents
2007
1.52
3
In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine.
Biochem Biophys Res Commun
2004
1.42
4
Effect of clarithromycin and azithromycin on production of cytokines by human monocytes.
Int J Antimicrob Agents
1999
1.36
5
Treatment With Lopinavir/Ritonavir or Interferon-β1b Improves Outcome of MERS-CoV Infection in a Nonhuman Primate Model of Common Marmoset.
J Infect Dis
2015
0.92
6
Hydroxychloroquine-induced cardiomyopathy: case report, pathophysiology, diagnosis, and treatment.
Can J Cardiol
2014
0.81
7
Molecular dynamic simulations analysis of ritonavir and lopinavir as SARS-CoV 3CL(pro) inhibitors.
J Theor Biol
2008
0.75
Next 100